These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 12588698)

  • 1. Effects of Bowman-Birk inhibitor on rat colon carcinogenesis.
    Kennedy AR; Billings PC; Wan XS; Newberne PM
    Nutr Cancer; 2002; 43(2):174-86. PubMed ID: 12588698
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of Bowman-Birk inhibitor and anti-Bowman-Birk inhibitor antibodies in sera of humans and animals treated with Bowman-Birk inhibitor concentrate.
    Wan XS; Serota DG; Ware JH; Crowell JA; Kennedy AR
    Nutr Cancer; 2002; 43(2):167-73. PubMed ID: 12588697
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Suppression of carcinogenesis in the intestines of min mice by the soybean-derived Bowman-Birk inhibitor.
    Kennedy AR; Beazer-Barclay Y; Kinzler KW; Newberne PM
    Cancer Res; 1996 Feb; 56(4):679-82. PubMed ID: 8630994
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preparation and production of a cancer chemopreventive agent, Bowman-Birk inhibitor concentrate.
    Kennedy AR; Szuhaj BF; Newberne PM; Billings PC
    Nutr Cancer; 1993; 19(3):281-302. PubMed ID: 8346077
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chemoprevention of rat prostate carcinogenesis by soy isoflavones and by Bowman-Birk inhibitor.
    McCormick DL; Johnson WD; Bosland MC; Lubet RA; Steele VE
    Nutr Cancer; 2007; 57(2):184-93. PubMed ID: 17571952
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Bowman-Birk inhibitor from soybeans as an anticarcinogenic agent.
    Kennedy AR
    Am J Clin Nutr; 1998 Dec; 68(6 Suppl):1406S-1412S. PubMed ID: 9848508
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of the Bowman-Birk inhibitor on clonogenic survival and cisplatin- or radiation-induced cytotoxicity in human breast, cervical, and head and neck cancer cells.
    Zhang L; Wan XS; Donahue JJ; Ware JH; Kennedy AR
    Nutr Cancer; 1999; 33(2):165-73. PubMed ID: 10368812
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of the Bowman-Birk protease inhibitor on survival of fibroblasts and cancer cells exposed to radiation and cis-platinum.
    Kennedy CW; Donahue JJ; Wan XS
    Nutr Cancer; 1996; 26(2):209-17. PubMed ID: 8875558
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Suppression of dimethylhydrazine-induced carcinogenesis in mice by dietary addition of the Bowman-Birk protease inhibitor.
    St Clair WH; Billings PC; Carew JA; Keller-McGandy C; Newberne P; Kennedy AR
    Cancer Res; 1990 Feb; 50(3):580-6. PubMed ID: 2297699
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Growth inhibition and cytotoxicity induced by Bowman-Birk inhibitor concentrate in cisplatin-resistant human ovarian cancer cells.
    Wan XS; Hamilton TC; Ware JH; Donahue JJ; Kennedy AR
    Nutr Cancer; 1998; 31(1):8-17. PubMed ID: 9682243
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protease inhibitor suppression of colon and anal gland carcinogenesis induced by dimethylhydrazine.
    Billings PC; Newberne PM; Kennedy AR
    Carcinogenesis; 1990 Jul; 11(7):1083-6. PubMed ID: 2372868
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of the Bowman-Birk inhibitor (a soy protein) on in vitro bladder neck/urethral and penile corporal smooth muscle activity.
    Malkowicz SB; Liu SP; Broderick GA; Wein AJ; Kennedy AR; Levin RM
    Neurourol Urodyn; 2003; 22(1):54-7. PubMed ID: 12478602
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proteases, protease inhibitors and radiation carcinogenesis.
    Kennedy AR
    Int J Radiat Biol; 2023; 99(6):882-890. PubMed ID: 34325613
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of spermine-conjugated Bowman-Birk inhibitor (spermine-BBI) on carcinogenesis and cholesterol biosynthesis in mice.
    Kennedy AR; Kritchevsky D; Shen WC
    Pharm Res; 2003 Dec; 20(12):1908-10. PubMed ID: 14725352
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Studies related to the potential antigenicity of the Bowman-Birk inhibitor, an anticarcinogenic protease inhibitor isolated from soybeans.
    Maki PA; Paterson Y; Kennedy AR
    Nutr Cancer; 1994; 22(2):185-93. PubMed ID: 14502847
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of various preparations of dietary protease inhibitors on oral carcinogenesis in hamsters induced by DMBA.
    Kennedy AR; Billings PC; Maki PA; Newberne P
    Nutr Cancer; 1993; 19(2):191-200. PubMed ID: 8502589
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction of apoptosis in the LNCaP human prostate carcinoma cell line and prostate adenocarcinomas of SV40T antigen transgenic rats by the Bowman-Birk inhibitor.
    Tang M; Asamoto M; Ogawa K; Naiki-Ito A; Sato S; Takahashi S; Shirai T
    Pathol Int; 2009 Nov; 59(11):790-6. PubMed ID: 19883429
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protection against adverse biological effects induced by space radiation by the Bowman-Birk inhibitor and antioxidants.
    Kennedy AR; Zhou Z; Donahue JJ; Ware JH
    Radiat Res; 2006 Aug; 166(2):327-32. PubMed ID: 16881733
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship between protease activity and neu oncogene expression in patients with oral leukoplakia treated with the Bowman Birk Inhibitor.
    Wan XS; Meyskens FL; Armstrong WB; Taylor TH; Kennedy AR
    Cancer Epidemiol Biomarkers Prev; 1999 Jul; 8(7):601-8. PubMed ID: 10428197
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cationized Bowman-Birk protease inhibitor as a targeted cancer chemopreventive agent.
    Ekrami H; Kennedy AR; Witschi H; Shen WC
    J Drug Target; 1993; 1(1):41-9. PubMed ID: 8069543
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.